Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Phase Two”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00602199
What this trial is testing

ABT-510 in Treating Patients With Metastatic Melanoma

Who this might be right for
Melanoma (Skin)
Mayo Clinic 42
Testing effectiveness (Phase 2)WithdrawnNCT05614453
What this trial is testing

Tislelizumab in Combination With Sitravatinib for Recurrent/Metastatic Cervical Cancer After Platinum-Based Chemotherapy

Who this might be right for
Metastatic Cervical Cancer
Australia New Zealand Gynaecological Oncology Group
Testing effectiveness (Phase 2)Study completedNCT02370537
What this trial is testing

Investigate How Common Pancreatic Exocrine Insufficiency (PEI) is in Patients With Type 2 Diabetes and Also to Investigate the Uptake of a Single Dose of EPANOVA® or OMACOR® in Patients With Different Degrees of PEI

Who this might be right for
Diabetes Mellitus, Type 2Exocrine Pancreatic Insufficiency
AstraZeneca 490
Testing effectiveness (Phase 2)Study completedNCT03796637
What this trial is testing

Assess Dystrophin Levels in Participants With Nonsense Mutation Duchenne Muscular Dystrophy (nmDMD) Who Have Been Treated With Ataluren

Who this might be right for
Duchenne Muscular Dystrophy
PTC Therapeutics 6
Testing effectiveness (Phase 2)Study completedNCT03560245
What this trial is testing

Bryostatin in Moderately Severe to Severe Alzheimer's Disease Subjects Not On Memantine

Who this might be right for
Alzheimer Disease
Neurotrope Bioscience, Inc. 108
Testing effectiveness (Phase 2)Study completedNCT00577577
What this trial is testing

Safety and Efficacy Study of Recombinant Human Insulin-Like Growth Factor-I/Recombinant Human Insulin-Like Growth Factor Binding Protein-3 (rhIGF-I/rhIGFBP-3) In Myotonic Dystrophy Type 1

Who this might be right for
Myotonic Dystrophy Type 1
Insmed Incorporated 69
Testing effectiveness (Phase 2)Study completedNCT00694057
What this trial is testing

Safety, Tolerance and Activity of HE3286 in Patients With Type 2 Diabetes Mellitus

Who this might be right for
Type 2 Diabetes Mellitus
Harbor Therapeutics 164
Testing effectiveness (Phase 2)Study completedNCT00092001
What this trial is testing

Study Of SU011248 In Patients With Metastatic Non-Small Cell Lung Cancer

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Pfizer 111
Testing effectiveness (Phase 2)Ended earlyNCT00484601
What this trial is testing

Ifosfamide and Doxorubicin in Patients With Refractory Nasopharyngeal Carcinoma

Who this might be right for
Refractory Nasopharyngeal Carcinoma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 9
Testing effectiveness (Phase 2)Study completedNCT04523181
What this trial is testing

Double-blind Study to Evaluate the Safety and Efficacy of Antroquinonol in Mild-Moderate COVID-19 Hospitalized Patients

Who this might be right for
Covid-19
Golden Biotechnology Corporation 124
Early research (Phase 1)Study completedNCT01032681
What this trial is testing

EMD 521873 in Advanced Solid Tumors, MTD Finding

Who this might be right for
Non-Hodgkin Lymphoma
Merck KGaA, Darmstadt, Germany 66
Testing effectiveness (Phase 2)Study completedNCT00313300
What this trial is testing

Safety Study of Apixaban in Recent Acute Coronary Syndrome

Who this might be right for
Acute Coronary Syndrome (ACS)
Bristol-Myers Squibb 1,741
Testing effectiveness (Phase 2)Study completedNCT05253807
What this trial is testing

Study to Evaluate the Efficacy and Safety of Pemigatinib in Participants With Relapsed or Refractory Advanced Non-Small Cell Lung Cancer With an FGFR Alteration

Who this might be right for
Non-Small Cell Lung Cancer (NSCLC)
Incyte Corporation 8
Testing effectiveness (Phase 2)Ended earlyNCT04544007
What this trial is testing

A Phase II Trial of Poly-ICLC for Low-Grade Gliomas

Who this might be right for
NF1Low-grade Glioma
University of Alabama at Birmingham 3
Large-scale testing (Phase 3)Looking for participantsNCT06819592
What this trial is testing

PRophylaxis Against Early VENTilator-associated Infections in Acute Brain Injury

Who this might be right for
All-cause MortalityQuality of LifeDisability, Intellectual+4 more
The George Institute 3,300
Testing effectiveness (Phase 2)Study completedNCT00368992
What this trial is testing

S0536: Cetuximab, Paclitaxel, Carboplatin, and Bevacizumab in Treating Patients With Advanced Non-Small Cell Lung Cancer

Who this might be right for
Adenocarcinoma of the LungAdenosquamous Cell Lung CancerBronchoalveolar Cell Lung Cancer+5 more
National Cancer Institute (NCI) 110
Early research (Phase 1)Ended earlyNCT04855136
What this trial is testing

Safety and Efficacy of bb2121 (Ide-cel) Combinations in Multiple Myeloma

Who this might be right for
Multiple Myeloma
Celgene 21
Testing effectiveness (Phase 2)Study completedNCT02876302
What this trial is testing

Study Of Ruxolitinib (INCB018424) With Preoperative Chemotherapy For Triple Negative Inflammatory Breast Cancer

Who this might be right for
Inflammatory Breast Cancer (IBC)
Dana-Farber Cancer Institute 23
Testing effectiveness (Phase 2)Study completedNCT00080353
What this trial is testing

Vaccine Treatment in Combination With IL-2 and Treated Lymphocytes for Advanced Melanoma

Who this might be right for
Melanoma
National Cancer Institute (NCI) 58
Testing effectiveness (Phase 2)Study completedNCT04553939
What this trial is testing

Neoadjuvant Toripalimab in Combination With Gemcitabine Therapy in Cisplatin Ineligible Local Advanved Bladder Cancer

Who this might be right for
Urothelial CarcinomaBladder Cancer
Henan Cancer Hospital 50
Next Page